Adipokines and cytokines in non-alcoholic fatty liver disease
- PMID: 18081738
- DOI: 10.1111/j.1365-2036.2007.03586.x
Adipokines and cytokines in non-alcoholic fatty liver disease
Abstract
Background: Several adipocytokines have been implicated in the pathogenesis non-alcoholic fatty liver disease (NAFLD).
Aim: To assess adipocytokines in NAFLD patients and controls.
Methods: A total of 95 patients (26 non-alcoholic steatohepatitis (NASH), 19 simple steatosis (SS), 38 obese controls and 12 non-obese controls) were included. Fasting serum insulin, glucose, visfatin, resistin, adiponectin, tumour necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8) and IL-6 were determined. Univariate and multivariate analyses were used to compare groups and determine associations.
Results: Serum TNF-alpha and IL-8 were higher in NAFLD patients when compared with both obese and non-obese controls. Analysis involving all patients revealed a significant correlation between serum TNF-alpha and IL-8 (P < 6.319e-08), and between IL-6 and IL-8 (P < 5.271e-15). Homeostatic model assessment scores negatively correlated with adiponectin in NAFLD (P < 0.0032). Serum visfatin was higher in all three obese groups than in non-obese controls (P < 0.02, P < 0.002 and P < 0.008). Visfatin in NASH patients was lower than SS and obese controls. Although TNF-alpha was associated with NAFLD (P < 0.02), it was interdependent on visfatin. In comparison to SS, four factors were independently associated with NASH: age, alanine aminotransferase, IL-8 and adiponectin (P < 0.05). Multivariate analysis indicated that TNF-alpha was the only independent predictor of fibrosis in NASH (P < 0.0004).
Conclusion: These findings support a complex interaction between adipocytokines and the pathogenesis of NAFLD.
Comment in
-
Adipokines and cytokines in non-alcoholic fatty liver disease.Aliment Pharmacol Ther. 2008 Jul;28(2):266-7; author reply 267-8. doi: 10.1111/j.1365-2036.2008.03697.x. Aliment Pharmacol Ther. 2008. PMID: 18611188 No abstract available.
-
Commentary: non-alcoholic steatohepatitis-finding and minding the fire behind the smoke.Aliment Pharmacol Ther. 2020 Jan;51(1):209-211. doi: 10.1111/apt.15565. Aliment Pharmacol Ther. 2020. PMID: 31850574 No abstract available.
Similar articles
-
Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.Ann Hepatol. 2013 Jul-Aug;12(4):548-55. Ann Hepatol. 2013. PMID: 23813132
-
Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.Ann Hepatol. 2013 Sep-Oct;12(5):749-57. Ann Hepatol. 2013. PMID: 24067262
-
Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.Clin Biochem. 2013 Feb;46(3):202-8. doi: 10.1016/j.clinbiochem.2012.11.006. Epub 2012 Nov 19. Clin Biochem. 2013. PMID: 23174488
-
[The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease].Postepy Hig Med Dosw (Online). 2010 May 7;64:212-9. Postepy Hig Med Dosw (Online). 2010. PMID: 20498498 Review. Polish.
-
Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy.Mediators Inflamm. 2009;2009:831670. doi: 10.1155/2009/831670. Epub 2009 Jun 3. Mediators Inflamm. 2009. PMID: 19753129 Free PMC article. Review.
Cited by
-
Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease.Clin Exp Med. 2014 May;14(2):121-31. doi: 10.1007/s10238-012-0227-0. Epub 2013 Jan 5. Clin Exp Med. 2014. PMID: 23292294 Review.
-
An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis.Hepatol Int. 2013 Dec;7 Suppl 2:800-5. doi: 10.1007/s12072-013-9479-3. Epub 2013 Dec 27. Hepatol Int. 2013. PMID: 26202294
-
Biochemical study of the effect of lead exposure in nonobese gasoline station workers and risk of hyperglycemia: A retrospective case-control study.Medicine (Baltimore). 2024 Aug 9;103(32):e39152. doi: 10.1097/MD.0000000000039152. Medicine (Baltimore). 2024. PMID: 39121307 Free PMC article.
-
Chinese Medicinal Herbs Targeting the Gut-Liver Axis and Adipose Tissue-Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science.Front Endocrinol (Lausanne). 2020 Sep 30;11:572729. doi: 10.3389/fendo.2020.572729. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33101207 Free PMC article. Review.
-
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease.Int J Mol Sci. 2023 Jan 24;24(3):2313. doi: 10.3390/ijms24032313. Int J Mol Sci. 2023. PMID: 36768637 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources